Skip to main content
. 2005 Jan 17;168(2):233–243. doi: 10.1083/jcb.200411005

Figure 1.

Figure 1.

Topographic markers at the NPC. Sketch of the site of GFP-POM121 (green), the binding sites of the primary antibody αNup358 (yellow), and the Alexa633-labeled secondary antibody (red). The range of geometrical binding configurations is indicated by the dashed circles, and spreads the experimentally observed label distribution by ±30 nm.

HHS Vulnerability Disclosure